Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health SystemStephen B. Williams, Stephen J. Freedland|JAMA Network Open|2021Cited by 58
Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013Kelly K. Bree, Stephen B. Williams|JAMA Network Open|2022Cited by 55
New horizons in bladder cancer researchJoost L. Boormans, Bernd J. Schmitz‐Dräger, Peter C. Black et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 10